LoginRegister
    Novo Nordisk files suit against Mylan to block entry of generic Victoza drug in USNovo Nordisk files suit against Mylan to block entry of generic Victoza drug in US
    GSK two-drug HIV injection shows promising resultGSK two-drug HIV injection shows promising result
    Lawmakers push Mylan, Teva Pharma over drug pricing probeLawmakers push Mylan, Teva Pharma over drug pricing probe
    OxyContin maker Purdue Pharma agrees to provide proprietary research, other dataOxyContin maker Purdue Pharma agrees to provide proprietary research, other data
    NPPA fixes MRP of 2 combo drugs manufactured by Emcure, Hetero Labs to prevent HIV; DetailsNPPA fixes MRP of 2 combo drugs manufactured by Emcure, Hetero Labs to prevent HIV; Details
    Glenmark gets USFDA nod for generic of Loestrin tablets to prevent pregnancyGlenmark gets USFDA nod for generic of Loestrin tablets to prevent pregnancy
    Faulty Hip Implants: JnJ pays Rs 25 lakh each to three victims in Uttar PradeshFaulty Hip Implants: JnJ pays Rs 25 lakh each to three victims in Uttar Pradesh
    Lupin unveils generic version of Prozac tablets in USLupin unveils generic version of Prozac tablets in US
    Zydus Cadila begins phase 2 trial for Saroglitazar Mg to treat NAFLD in women with PCOSZydus Cadila begins phase 2 trial for Saroglitazar Mg to treat NAFLD in women with PCOS
    Oklahoma judge to rule in opioid lawsuit against JnJOklahoma judge to rule in opioid lawsuit against JnJ
    Allergan, Endo agree to USD 15 million settlement in major opioid caseAllergan, Endo agree to USD 15 million settlement in major opioid case
    Rationalisation of 294 FDC drugs: CDSCO issues Fresh directions to manufacturersRationalisation of 294 FDC drugs: CDSCO issues Fresh directions to manufacturers
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X